help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 22, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1989
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
93/5/1609    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PIGNY, P.
Right arrow Articles by CARON, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PIGNY, P.
Right arrow Articles by CARON, P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Substance via MeSH
Medline Plus Health Information
*Head and Neck Cancer
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Cardiovascular Endocrinology
Right arrow Endocrine Oncology

Submitted on September 5, 2007
Accepted on January 14, 2008

Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation

Pascal PIGNY*, Audrey VINCENT, Catherine CARDOT BAUTERS, Monelle BERTRAND, Vincent THOMAS de MONTPREVILLE, Michel CREPIN, Nicole PORCHET, and Philippe CARON

Laboratoire de Biochimie & Hormonologie, Centre de Biologie et Pathologie, CHRU, 59037 LILLE cedex, France; INSERM U837, Centre de Recherche Jean Pierre Aubert, 59045 LILLE cedex, France; Service d'Endocrinologie & Maladies Métaboliques, Clinique Marc LINQUETTE, CHRU, 59037 LILLE cedex, France; Service d'Endocrinologie & Maladies métaboliques, Hôpital de Rangueil, CHU, 31059 TOULOUSE cedex, France; Service d'Anatomie pathologique, Centre chirugical Marie Lannelongue, 92350 LE PLESSIS ROBINSON

* To whom correspondence should be addressed. E-mail: p-pigny{at}chru-lille.fr.

Context: Inactivating mutations of SDHD, which is mapped to 11q23 and encodes the cybS subunit of succinate dehydrogenase, predispose to hereditary paraganglioma (hPGL) and/or pheochromocytoma. So far no disease was shown to occur in case of maternal transmission of a SDHD mutation, suggesting the existence of genomic imprinting. A hypothetic model, involving the loss of the maternal copy of a tumor suppressor gene mapped to 11p15 in the tumoral tissue, has been proposed to explain this mode of inheritance.

Objective: Our objective was to investigate the possibility of maternal transmission of SDHD-linked PGL.

Design: A three generations family carrying the SDHD W43X mutation was studied at the clinical, pathological and genetical levels.

Results: The germline's mutation was probably inherited from the grand-father. At the second generation three carriers (two females and one male), who had the same at risk 11q13-q23 haplotype, developed multiple cervical PGLs. At the third generation, one boy received the mutation from his mother and developed a glomus tympanicum PGL at 11. He only shared the 11q23 haplotype with the other affected members of the family. Methylation analysis of the differentially methylated region (DMR) upstream of the maternally expressed H19 gene, mapped to 11p15, showed that the seventh CTCF binding site is hypermethylated in the germline of the affected boy suggesting a gain of imprinting.

Conclusion: Our data show that maternal transmission of a SDHD-linked PGL, even if a rare event, can occur. Therefore we propose that children who inherited a pathogenic mutation from their mother should be considered as at-risk of PGL.


Key words: SDHD • paraganglioma • imprinting







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society